Analysis of immunological abnormalitiy in inflammatory skin diseases

Analysis of immunological abnormalitiy in inflammatory skin diseases - Analysis of immunological abnormalitiy in inflammatory skin diseases

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000032330

Enrollment

Registered

2018-05-01

Start date

2014-04-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atopic dermatitis, psoriasis, Behcet&#39

Interventions

To take blood samples from patients To take blood samples from healthy controls

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients with atopic dermatitis, psoriasis, Behcet disease, and other inflammatory skin diseases. healthy controls (over 18 year old, under 70 year old).

Exclusion criteria

Exclusion criteria: persons which is not involed in the category above.

Design outcomes

Primary

Measure	Time frame
To evaluate the abnormality of cytokine production and signal transduction pathways induced by inflammatory cells	—

Countries

Japan

Contacts

Public ContactKoichiro Nakamura

Saitama Medical University Department of Dermatology

nakamu@saitama-med.ac.jp049-276-1247

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026